Sagimet Biosciences Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Sagimet Biosciences Inc. (SGMT) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$23.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2024-05-15
- Sagimet Biosciences Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2024-03-31 was -$23.00K, a 132.39% decline year-over-year.
- Sagimet Biosciences Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2023-12-31 was $30.00K, a 61.54% decline year-over-year.
- Sagimet Biosciences Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2023-09-30 was $0.00.
- Sagimet Biosciences Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2023-06-30 was $13.00K.
- Sagimet Biosciences Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $114.00K.
- Sagimet Biosciences Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$84.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2024-03-31 | -$23.00K 10-Q · filed 2024-05-15 | $7.00K derived: sum of 2 quarters · filed 2024-05-15 | $7.00K derived: sum of 3 quarters · filed 2024-05-15 | $20.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $30.00K derived: sum of 2 quarters · filed 2024-03-25 | $43.00K derived: sum of 3 quarters · filed 2024-03-25 | $114.00K 10-K · filed 2024-03-25 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $13.00K derived: sum of 2 quarters · filed 2023-11-13 | $84.00K 10-Q · filed 2023-11-13 | $162.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-06-30 | $13.00K 10-Q · filed 2023-08-21 | $84.00K 10-Q · filed 2023-08-21 | $162.00K derived: sum of 3 quarters · filed 2024-05-15 | $106.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-03-31 | $71.00K 10-Q · filed 2024-05-15 | $149.00K derived: sum of 2 quarters · filed 2024-05-15 | $93.00K derived: sum of 3 quarters · filed 2024-05-15 | -$13.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $22.00K derived: sum of 2 quarters · filed 2024-03-25 | -$84.00K derived: sum of 3 quarters · filed 2024-03-25 | -$84.00K 10-K · filed 2024-03-25 |
| 2022-09-30 | -$56.00K 10-Q · filed 2023-11-13 | -$162.00K derived: sum of 2 quarters · filed 2023-11-13 | -$162.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$106.00K 10-Q · filed 2023-08-21 | -$106.00K 10-Q · filed 2023-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |